本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Recursion Pharmaceuticals, Inc.

3.24
-0.1700-4.99%
盤前3.260.0200+0.62%04:06 EDT
成交量:1,188.13萬
成交額:3,877.06萬
市值:17.33億
市盈率:-3.17
高:3.37
開:3.37
低:3.22
收:3.41
52周最高:7.18
52周最低:2.77
股本:5.35億
流通股本:5.22億
量比:0.91
換手率:2.27%
股息:- -
股息率:- -
每股收益(TTM):-1.0219
每股收益(LYR):-1.4410
淨資產收益率:-56.58%
總資產收益率:-27.33%
市淨率:1.89
市盈率(LYR):-2.25

資料載入中...

2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/20

重要事件披露

Form 8-K - Current report